Tag: Clinical Trials
UK Biocentre Granted ISO 15189:2012 Accreditation for Sample Processing and Storage Services
UK Biocentre has been granted ISO 15189:2012 Accreditation by UKAS for sample processing and storage services. This landmark accreditation further extends UK Biocentre’s capabilities, increasing the scope of services it can provide to support clinical trials and studies, including...
Grünenthal And Mesoblast Partner To Develop Allogeneic Cell Therapy For Chronic Low Back Pain
Grünenthal, a global leader in pain management, and
Mesoblast Limited, a world leader in allogeneic cellular medicines for
inflammatory diseases, have entered into a strategic partnership to develop and
commercialise MPC-06-ID, a Phase III allogeneic cell therapy candidate for the
treatment of chronic...
Mission Bio And Onconova Partner To Use Tapestri® Platform Single-Cell DNA Analysis In Clinical...
Mission Bio, the pioneer in targeted single-cell DNA
analysis and precision genomics, and Onconova Therapeutics, have formed a
collaboration to utilize the Mission Bio Tapestri®
Platform for targeted single-cell DNA analysis to study Onconova’s novel cancer
therapy, rigosertib, through clinical trials. Founded in 2012,...
Meeting – C-Path and NORD Launch The Rare Disease Cures Accelerator-Data and Analytics Platform
The Critical Path Institute (C-Path) and the National Organization for Rare Disorders® (NORD) will host a meeting on Tuesday, September 17 in Bethesda, Maryland, to formally launch development of a new rare disease data and analytics platform. Funded by...
Gamida Cell Presented Omidubicel Cell Therapy For Blood Cancers At ISCT Meeting In Melbourne
Two presentations on omidubicel (formerly known as NiCord®),
an investigational advanced cell therapy in Phase 3 clinical development
designed to enhance the life-saving benefits of hematopoietic stem cell (bone
marrow) transplant, developed by Gamida Cell Ltd., a leading cellular and
immune therapeutics company,...
Circuit Clinical™ Partners With CUBRC Applying Machine Learning To Predict Therapy Response
Circuit Clinical™, one of the USA's largest integrated research organizations dedicated to empowering patients to choose clinical research as a care option, has announced a ground-breaking strategic partnership with CUBRC (Calspan-University at Buffalo Research Center), a company specializing in...
Basic Research And Treatment Strategies For Hereditary Aggrecan Deficiency Awarded
Recently, an international team of researchers received the
2019 Human Growth Award at the Pediatric Endocrine Society's Annual Meeting for
their abstract, entitled "Clinical Characterization and Trial of Growth
Hormone in Patients with Aggrecan Deficiency: 6 Month Data," and presented
this at the...
CloudLIMS Released Kits Module For Clinical Research And Testing Laboratories
CloudLIMS, a leading laboratory data management informatics provider, has announced the release of a Kits module for its Laboratory Information Management System (LIMS), CloudLIMS. The Kits module is for clinical research and testing laboratories, enabling them to create kit...
Cellect Prepared For US Clinical Trial
Cellect Biotechnology Ltd. has announced a collaboration with Washington University in St. Louis, Missouri, USA, in a U.S. Phase I/II study aimed at determining the safety and tolerability of using ApoGraft™ for bone marrow transplantations. Founded in 2011, located in...
StemCyte Receives IND Clearance Of Mononuclear Stem Cells In Spinal Cord Injury Clinical Trials
On December 14, 2018, the U.S. Food and Drug Administration
(FDA), approved StemCyte’s Phase II Investigational New Drug (IND) application
for Allogeneic Human Leukocyte Antigen (HLA)-Matched Umbilical Cord Blood
Mononuclear Stem Cells (UCBMNC) (MC001) for the treatment of spinal cord
injury. Founded in 1997,...
